NCT00408148 - High Density Lipoprotein Turnover | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Obesity

Interventions

DRUG

Placebo

Undistinguishable placebo tablets

DRUG

Rimonabant

White film-coated, for oral administration containing 20 mg of active rimonabant

Trial Locations (4)

Sanofi-Aventis Administrative Office, North Ryde

Sanofi-Aventis Administrative Office, Helsinki

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Guildford